NCT02026011View on ClinicalTrials.gov

Naltrexone for Individuals of East Asian Descent

PHASE2CompletedINTERVENTIONAL
Enrollment

87

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions
Alcohol Use Disorder
Interventions
DRUG

Naltrexone

Naltrexone is an opioid receptor antagonist with highest affinity for mu opioid receptors

DRUG

Placebo

Sugar pill, matched to the active study medication in capsule size and color

Trial Locations (1)

90095

UCLA Addictions Laboratory, Los Angeles

All Listed Sponsors
collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

University of California, Los Angeles

OTHER

NCT02026011 - Naltrexone for Individuals of East Asian Descent | Biotech Hunter | Biotech Hunter